Efficacy and Safety of Tocilizumab for Acute Chest Syndrome Treatment in Patients With Sickle Cell Disease
Clinical trial NCT06818266 · RECRUITING
Trial details
- NCT number
- NCT06818266
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-27
- Primary completion
- 2027-04-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.